A prospective study of the safety and efficacy of a combined bipolar radiofrequency, intense pulsed light, and infrared diode laser treatment for global facial photoaging
Authors:
- 23 April 2017
- journal article
- clinical trial
- Published by Springer Nature in Lasers in Medical Science
- Vol. 32 (5) , 1051-1061
Abstract
The clinical features of photoaging include: skin texture changes, laxity, rhytides, pigmentary changes, and vascular changes such as erythema and telangiectasias. In order to meet patients’ increasing demands for improving all aspects of photoaging at one office visit, employing a multi-modality treatment for all aspects of photoaging has become increasingly desirable for the physician and patient alike. We examine a novel device that employs bipolar radiofrequency (RF), intense pulsed light (IPL), and infrared diode laser. These laser and light source treatments are performed sequentially. This study aims to evaluate the clinical efficacy and safety of this device (i.e., ELOS Triniti™). Twenty-six subjects received four ELOS Triniti™ treatments at 1-month intervals. They were followed up 1, 3, and 6 months after completing the treatments. Two blinded dermatologists used a comprehensive grading scale to evaluate the degree of the photoaging in terms of rhytides, laxity, dyschromia, erythema, telangiectasias, and texture. Subjects used a 0–10 grading scale for self-assessment of photoaging. Additionally, we measured the Erythema Index (EI), Melanin Index (MI), transepidermal water loss scores (TEWL), stratum corneum moisture scores (SC), and dermis moisture scores (D) before treatment and 1, 3, and 6 months after treatment. There was a statistically significant improvement in all five aspects of the comprehensive grading scale. Overall, it had excellent efficacy for improving erythema, telangiectasias, and skin texture. It also had a relatively long effect on improving skin laxity; however, it had only a limited ability to improve rhytides and dyschromia. It can mildly to moderately improve the global photoaging. This global effect can be noted 1 month after treatment and becomes most clinically apparent 3 months after treatment. This is maintained at least 6 months after treatment. MI index and SC and D values increased while EI index and TEWL values decreased after the treatment. The subjects’ self-assessment improved by 2.7 ± 1.2 points. The overall satisfaction rate was 88%. The degree of pain measured 2.5 ± 1.9 points on average. There was no downtime and no severe side effects reported. The sequential implementation of bipolar radiofrequency based optical combination devices (IPL, IR, diode laser) is effective and safe for global facial photoaging.Keywords
This publication has 32 references indexed in Scilit:
- Clinical evaluation of a non-ablative 1940 nm fractional laser.2014
- Melasma-like hyperpigmentation induced by intense pulsed light treatment in Chinese individualsJournal of Cosmetic and Laser Therapy, 2014
- The Role of the Extracellular Matrix Components in Cutaneous Wound HealingBioMed Research International, 2014
- Combination Treatment Using Bipolar Radiofrequency-Based Intense Pulsed Light, Infrared Light and Diode Laser Enhanced Clinical Effectiveness and Histological Dermal Remodeling in Asian Photoaged SkinDermatologic Surgery, 2012
- Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency.2008
- Versican V0 and V1 Guide Migratory Neural Crest CellsJournal of Biological Chemistry, 2006
- Nonablative Wrinkle Treatment of the Face and Neck Using a Combined Diode Laser and Radiofrequency TechnologyDermatologic Surgery, 2005
- Enhanced full-face skin rejuvenation using synchronous intense pulsed optical and conducted bipolar radiofrequency energy (ELOS): introducing selective radiophotothermolysis.2005
- Evaluation of pulsed light and radiofrequency combined for the treatment of acne vulgaris with histologic analysis of facial skin biopsiesJournal of Cosmetic and Laser Therapy, 2005
- Characteristics of the In Vitro Interaction of a Small Proteoglycan (PG II) of Bovine Tendon with Type I CollagenMatrix, 1990